Akero Therapeutics Inc [AKRO] is 17.22% higher this YTD. Is it still time to buy?
Akero Therapeutics Inc [NASDAQ: AKRO] loss -2.15% on the last trading session, reaching $27.37 price per share at the time. The company report on March 8, 2024 at 4:02 PM that Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of